Wang et al. [42] first revealed miR-610 as a new epidermal growth factor (EGF)-regulated miRNA that targets VASP in GC cells, suggesting the possibility of artificially interfering with the EGF-miR610-VASP axis to inhibit the GC development. The gene discussed is VASP; the disease is gastric cancer.